These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15729852)

  • 21. Rational Drug Design of Antineoplastic Agents Using 3D-QSAR, Cheminformatic, and Virtual Screening Approaches.
    Vucicevic J; Nikolic K; Mitchell JBO
    Curr Med Chem; 2019; 26(21):3874-3889. PubMed ID: 28707592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Molecular Descriptors on Computational Models.
    Grisoni F; Consonni V; Todeschini R
    Methods Mol Biol; 2018; 1825():171-209. PubMed ID: 30334206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix-based Molecular Descriptors for Prospective Virtual Compound Screening.
    Grisoni F; Reker D; Schneider P; Friedrich L; Consonni V; Todeschini R; Koeberle A; Werz O; Schneider G
    Mol Inform; 2017 Jan; 36(1-2):. PubMed ID: 27650559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accurate prediction for atomic-level protein design and its application in diversifying the near-optimal sequence space.
    Fromer M; Yanover C
    Proteins; 2009 May; 75(3):682-705. PubMed ID: 19003998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and characterization of novel sodium/potassium-ATPase inhibitors by virtual screening of a compound database.
    Stanton DT; Ankenbauer J; Rothgeb D; Draper M; Paula S
    Bioorg Med Chem; 2007 Sep; 15(18):6062-70. PubMed ID: 17618121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic Comparison of the Performance of Different 2D and 3D Ligand-Based Virtual Screening Methodologies to Discover Anticonvulsant Drugs.
    Di Ianni ME; Gantner ME; Ruiz ME; Castro EA; Bruno-Blanch LE; Talevi A
    Comb Chem High Throughput Screen; 2015; 18(4):387-98. PubMed ID: 25747440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving virtual screening predictive accuracy of Human kallikrein 5 inhibitors using machine learning models.
    Fang X; Bagui S; Bagui S
    Comput Biol Chem; 2017 Aug; 69():110-119. PubMed ID: 28601761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of ligand- and structure-based virtual screening on the DUD data set.
    von Korff M; Freyss J; Sander T
    J Chem Inf Model; 2009 Feb; 49(2):209-31. PubMed ID: 19434824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flexophore, a new versatile 3D pharmacophore descriptor that considers molecular flexibility.
    von Korff M; Freyss J; Sander T
    J Chem Inf Model; 2008 Apr; 48(4):797-810. PubMed ID: 18393490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ROCS-derived features for virtual screening.
    Kearnes S; Pande V
    J Comput Aided Mol Des; 2016 Aug; 30(8):609-17. PubMed ID: 27624668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of correlation vector methods for ligand-based similarity searching.
    Fechner U; Franke L; Renner S; Schneider P; Schneider G
    J Comput Aided Mol Des; 2003 Oct; 17(10):687-98. PubMed ID: 15068367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virtual screening in drug discovery -- a computational perspective.
    Reddy AS; Pati SP; Kumar PP; Pradeep HN; Sastry GN
    Curr Protein Pept Sci; 2007 Aug; 8(4):329-51. PubMed ID: 17696867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flexible 3D pharmacophores as descriptors of dynamic biological space.
    Nettles JH; Jenkins JL; Williams C; Clark AM; Bender A; Deng Z; Davies JW; Glick M
    J Mol Graph Model; 2007 Oct; 26(3):622-33. PubMed ID: 17395510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of benchmark data set topology on the validation of virtual screening methods: exploration and quantification by spatial statistics.
    Rohrer SG; Baumann K
    J Chem Inf Model; 2008 Apr; 48(4):704-18. PubMed ID: 18380447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination and mapping of activity-specific descriptor value ranges for the identification of active compounds.
    Eckert H; Bajorath J
    J Med Chem; 2006 Apr; 49(7):2284-93. PubMed ID: 16570925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ligand-based computer-aided discovery of tyrosinase inhibitors. Applications of the TOMOCOMD-CARDD method to the elucidation of new compounds.
    Marrero-Ponce Y; Casañola-Martín GM; Khan MT; Torrens F; Rescigno A; Abad C
    Curr Pharm Des; 2010; 16(24):2601-24. PubMed ID: 20642427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular descriptors in chemoinformatics, computational combinatorial chemistry, and virtual screening.
    Xue L; Bajorath J
    Comb Chem High Throughput Screen; 2000 Oct; 3(5):363-72. PubMed ID: 11032954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stochastic versus stepwise strategies for quantitative structure-activity relationship generation--how much effort may the mining for successful QSAR models take?
    Horvath D; Bonachera F; Solov'ev V; Gaudin C; Varnek A
    J Chem Inf Model; 2007; 47(3):927-39. PubMed ID: 17480052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How diverse are diversity assessment methods? A comparative analysis and benchmarking of molecular descriptor space.
    Koutsoukas A; Paricharak S; Galloway WR; Spring DR; Ijzerman AP; Glen RC; Marcus D; Bender A
    J Chem Inf Model; 2014 Jan; 54(1):230-42. PubMed ID: 24289493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and Validation of Molecular Overlays Derived from Three-Dimensional Hydrophobic Similarity with PharmScreen.
    Vázquez J; Deplano A; Herrero A; Ginex T; Gibert E; Rabal O; Oyarzabal J; Herrero E; Luque FJ
    J Chem Inf Model; 2018 Aug; 58(8):1596-1609. PubMed ID: 30010337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.